Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

China’s first mRNA vaccine is close — will that solve its COVID woes?

Researchers say a highly effective jab will help to avoid hospitals getting overwhelmed, but probably won’t end the country’s ‘zero COVID’ policy.
  1. Yvaine Ye
    View author publications

    You can also search for this author in PubMed  Google Scholar

China is getting closer to approving its first mRNA vaccine to protect people against COVID-19. In a small clinical trial, the Chinese vaccine candidate triggered a stronger antibody response in vaccinated adults when given as a booster shot than did a jab containing inactivated SARS-CoV-2, the vaccine platform that the country has mostly relied on so far.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-022-01690-3

References

  1. McMenamin, M. E. et al. Preprint at medRxiv https://doi.org/10.1101/2022.03.22.22272769 (2022).

  2. Hui, A.-M. et al. Preprint at SSRN https://doi.org/10.2139/ssrn.4114061 (2022).

  3. Liu, X. et al. Preprint at medRxiv https://doi.org/10.1101/2022.05.30.22275753 (2022).

  4. Li, J.-X. et al. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(22)00087-X (2022).

    Article  PubMed  Google Scholar 

  5. Lauring, A. S. et al. BMJ 376, e069761 (2022).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links